D
Anavex Life Sciences Corp. AVXL
$9.43 -$0.105-1.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -15.99% -16.13% -7.73% 9.48% 19.60%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -6.19% -33.25% -34.95% -45.18% -47.42%
Change in Net Operating Assets 20.58% 340.72% 642.21% 9.86% -82.64%
Cash from Operations -23.65% 8.20% -21.51% -10.89% -15.48%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -87.32% -66.30% -57.14% -59.61% -49.48%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -103.54% -66.30% -57.14% -59.61% -49.48%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -134.06% -67.71% -16,176.92% -1,109.49% -1,093.01%